VCM
FLGT icon

Versant Capital Management’s Fulgent Genetics FLGT Stock Holding History

Versant Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.2K Buy
1,007
+10
+1% +$201 ﹤0.01% 1908
2026
Q2 		$20.5K Sell
997
-1,694
-63% -$28.7K ﹤0.01% 1912
2026
Q1 		$42.8K Buy
2,691
+1,234
+85% +$26.8K ﹤0.01% 1333
2025
Q4 		$38.3K Hold
1,457
– – ﹤0.01% 1231
2025
Q3 		$32.9K Sell
1,457
-663
-31% -$13.7K ﹤0.01% 1277
2025
Q2 		$42.1K Buy
2,120
+694
+49% +$13.5K 0.01% 1074
2025
Q1 		$24.1K Buy
1,426
+434
+44% +$7.39K ﹤0.01% 1245
2024
Q4 		$18.3K Buy
992
+506
+104% +$9.88K ﹤0.01% 1079
2024
Q3 		$10.6K Buy
486
+148
+44% +$3.31K ﹤0.01% 1041
2024
Q2 		$6.63K Buy
338
+210
+164% +$4.38K ﹤0.01% 1131
2024
Q1 		$2.78K Hold
128
– – ﹤0.01% 1247
2023
Q4 		$3.7K Buy
128
+81
+172% +$2.17K ﹤0.01% 1080
2023
Q3 		$1.26K Sell
47
-317
-87% -$10.8K ﹤0.01% 1465
2023
Q2 		$13.5K Sell
364
-85
-19% -$2.96K ﹤0.01% 656
2023
Q1 		$14K Buy
+449
New +$14.4K ﹤0.01% 617

Other funds holding FLGT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return

Versant Capital Management's FLGT Position: Q3 2026 in Review

Versant Capital Management increased its Fulgent Genetics (FLGT) stake by 1% in Q3 2026, buying an estimated $201 and bringing the position to 1,007 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Versant Capital Management first reported a position in FLGT in Q1 2023 and has held it in 15 quarters since. The position peaked at $42.8K in Q1 2026. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Versant Capital Management held 1,007 shares of Fulgent Genetics worth $22.2K as of Q3 2026.
  • Versant Capital Management bought 10 Fulgent Genetics shares in Q3 2026, an estimated $201.
  • Fulgent Genetics made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1908 holding.
  • Versant Capital Management first reported a position in Fulgent Genetics in Q1 2023 and has held it in 15 quarters since.
  • Versant Capital Management's Fulgent Genetics position peaked at $42.8K in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.